In vitro activity of BMY-28100, a new oral cephalosporin
- 1 April 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (4) , 653-656
- https://doi.org/10.1128/aac.31.4.653
Abstract
The activity of BMY-28100, a new orally administered cephalosporin, was compared with those of cephalexin and cefaclor. BMY-28100 was the most active drug against Staphylococcus aureus (MIC for 90% of strains tested [MIC90], 1.0 microgram/ml), streptococci (MIC90S, less than or equal to 0.125 microgram/ml), and Klebsiella pneumoniae (MIC90, 2 micrograms/ml). The drug was active against Haemophilus influenzae and gonococci but not against other organisms generally resistant to cephem antibiotics.This publication has 3 references indexed in Scilit:
- In-vitro activity of Sch 29482 in comparison with other oral antibioticsJournal of Antimicrobial Chemotherapy, 1982
- Diphtheroid prosthetic valve endocarditisThe American Journal of Medicine, 1980
- Effect of Protein Binding on the Activity of Penicillins in Combination with Gentamicin Against EnterococciAntimicrobial Agents and Chemotherapy, 1979